SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form SC 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]
SEC Accession No. 0001104659-18-009005
Filing Date
2018-02-13
Accepted
2018-02-13 16:05:33
Documents
1

Document Format Files

Seq Description Document Type Size
1 SC 13G/A a18-5768_1sc13ga.htm SC 13G/A 73397
  Complete submission text file 0001104659-18-009005.txt   74692
Mailing Address 17199 N. LAUREL PARK DRIVE SUITE 401 LIVONIA MI 48152
Business Address
Bisgaier Charles PhD (Filed by) CIK: 0001381030 (see all company filings)

Type: SC 13G/A

Mailing Address 17199 N. LAUREL PARK DRIVE SUITE 401 LIVONIA MI 48152
Business Address 17199 N. LAUREL PARK DRIVE SUITE 401 LIVONIA MI 48152 248-980-6538
Gemphire Therapeutics Inc. (Subject) CIK: 0001638287 (see all company filings)

IRS No.: 472389984 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13G/A | Act: 34 | File No.: 005-89598 | Film No.: 18603266
SIC: 2834 Pharmaceutical Preparations